29% want vaccine from the USA; only 9% say they prefer immunizing from China

 29% want vaccine from the USA; only 9% say they prefer immunizing from China

Search PoderData shows that 29% of Brazilians prefer to have a vaccine against covid-19 that is made in the United States. Another 20% say that, if they could, they would choose 1 immunizer that was made by European countries.

Among supporters of President Jair Bolsonaro, 33% prefer the vaccine from the United States and only 2% from China

© Pixabay / Edition Poder360
Among supporters of President Jair Bolsonaro, 33% prefer the vaccine from the United States and only 2% from China

The percentage of those who choose vaccines developed by pharmaceutical companies in China or Russia is lower, 9% and 3%, respectively.

All rates varied within the margin of error of 2 percentage points in relation to the last liftthe, done from 17 to 19 of August.

© Provided by Poder360

The research was carried out by PoderData, statistical studies division do Poder360. The survey is disseminated in editorial partnership like Bandeirantes Group.

The data were collected from October 26 to 28, through calls to cell phones and landlines. There were 2,500 interviews in 488 municipalities, in the 27 units of the Federation. The margin of error is 2 percentage points. Learn more about the methodology by reading this text.

In order to reach 2,500 interviews that proportionally fill (as they appear in society) the groups by sex, age, income, education and geographic location, the PoderData makes tens of thousands of phone calls. Often, more than 100 thousand calls until Brazilians are found who faithfully represent the population as a whole.

The survey was made shortly after the impact of the clash between President Jair Bolsonaro and the governor of São Paulo, João Doria (PSDB). Fierce opponents, the president and the toucan disagree about the mandatory vaccine.

Furthermore, on October 21, contrary to China’s vaccine, Bolsonaro canceled 1 agreement signed by the Ministry of Health for the acquisition of 46 million doses of CoronaVac, immunizer against covid-19 developed by the Chinese pharmaceutical company Sinovac Biotech in partnership with the Butantan Institute, in São Paulo.

Faced with resistance from the federal government, Doria decided to close the contract for the purchase of CoronaVac. Of the 46 million doses of the immunizer, 40 million will be produced in Brazil. Last Wednesday (28.out.2020), Anvisa (National Health Surveillance Agency) authorized the import of raw material from China for vaccine production.

The themes reverberated strongly in the media, mainly in a negative way. In WhatsApp groups, popped up videos of alleged doctors and health professionals – criticizing and praising the government.

After the mobilization of parties, both the mandatory vaccine and the withdrawal of the purchase of CoronaVac by the federal government will be analyzed by the STF (Supreme Federal Court).

O PoderData it also showed that 56% of Brazilians defend the mandatory vaccine and 36% are against this measure.

© Provided by Poder360

The research division of Poder360 also indicates that 63% of Brazilians “Would definitely take” the coronavirus vaccine if it was already available.


O PoderData separated the survey by gender, age, region, education and income. The highest percentages of preference are observed in the following groups and regions:

  • Vaccine made in China: men (10%); people aged 60 or over (15%); those with higher education (12%); residents of the Northeast (12%); and those earning 5 to 10 minimum wages (19%);
  • Vaccine made in the United States – men (32%); people aged 16 to 24 (43%); those with only elementary education (33%); residents of the North region (43%); and the unemployed or without fixed income (33%);
  • Vaccine made in Europe – men (25%); those aged 25 to 44 and those aged 60 or over (22% in each stratum); those with secondary and higher education (26% in each stratum); residents of the South (27%) and those who earn more than 10 minimum wages (43%);
  • Vaccine made in Russia – women (4%); those aged 16 to 24 and 45 to 59 years old (3% in each stratum); those with only elementary education (3%); residents of the Midwest (10%); and the unemployed or without fixed income (4%).

Read the complete stratification in the infographic below:

© Provided by Poder360

Currently, 4 clinical studies of coronavirus vaccines are being carried out in Brazil, all of which are in the 3rd and final testing phase. Here are what they are:

  • Oxford Vaccine – produced by the Swedish laboratory AstraZeneca and for Oxford University, from England;
  • CoronaVac – developed by the Chinese company Sinovac in partnership with Butantan Institute;
  • BNT162b1 vaccine – developed by the German biotechnology company BioNTech and by the American pharmaceutical company Pfizer;
  • Vacina Jansen-Cilag – produced by the Belgian pharmaceutical company Janssen, of the North American group Johnson-Johnson.

In the world, the 1st vaccine that received regulatory approval was that of Russia: the Sputinik V, developed by the Gamaleya Institute in Moscow. Last Tuesday (27.out.2020), the country asked WHO (World Health Organization) to approve the emergency use of the immunizer.


President Jair Bolsonaro and part of his support base, including your children, routinely glorify the approach of the federal administration to the United States government, which anticipated in July the purchase of US $ 1.95 billion in vaccines from Pfizer and BioNTech.

Bolsonaro, however, has not yet expressed any preference over any vaccine, but he said contrary to China. Last Monday (October 26, 2020), the president was still defended the investment in the treatment disease instead of producing 1 immunizer against the coronavirus, which has killed more than 158,400 people in the country.

“Isn’t it easier and even cheaper to invest in a cure than in a vaccine?”, questioned his supporters. “Apparently, everyone who dealt early with one of these 3 alternatives there [hidroxicloroquina, ivermectina e o vermífugo Anitta] was healed“, said.

The position of the president seems to influence those who positively evaluate their individual work in the presidency. Of those who think Bolsonaro “great” or “good”, 33% prefer to get a vaccine made in the United States and only 2% prefer 1 immunizer produced by China.

As for those who think the president “spacious” or “terrible”, 29% prefer a formula developed in Europe. Another 18% prefer Chinese production and 2% prefer one made in Russia.

© Provided by Poder360

Considering the evaluation of the federal government in general, of those who approve the government, 36% have a preference for a North American vaccine and only 2% opt for the Russian vaccine.

Among those who disapprove of the government, 29% prefer 1 immunizer produced in Europe, 18% that of the USA, 17% that of China and only 2% want that of Russia.


Read more about the research PoderData:

The content of the PoderData can be read on social networks, where infographics and news are shared. Follow the profiles of the research division of Poder360 no Twitter, no Facebook, no Instagram and no LinkedIn.

Information from this post was published before by Drive, with exclusivity. The newsletter is produced for subscribers by the team of journalists from Poder360. Know more Drive on here and learn how to receive all key information from power and politics in advance.


Please enter your comment!
Please enter your name here